Media Summary: Learn more about SynGAP research at: In this video Dr Nadav Ahituv presents Modulating ... Presentation by Heather Stone, Health Science Policy Analyst, US Food & Funding Priorities. Biorepository. Genetic Testing. How to move for a clinical trial! Monday, February 2, 2026 - Week 6 ...

Cure Syngap1 Cure Id A Treatment Registry Of Repurposed Drugs For Syngap1 Mp4 - Detailed Analysis & Overview

Learn more about SynGAP research at: In this video Dr Nadav Ahituv presents Modulating ... Presentation by Heather Stone, Health Science Policy Analyst, US Food & Funding Priorities. Biorepository. Genetic Testing. How to move for a clinical trial! Monday, February 2, 2026 - Week 6 ... universityofnewcastle Professor Nikola Bowden, Co-director of HMRI's Episode 12: “A Close Look At Sanfilippo” Johns Hopkins gastroenterologist Florin Selaru and nanomedicine researcher Laura Ensign discuss their work addressing one of ...

Childhood Cancer: Causes and Epidemiology The role of genetic predisposition and environment in development and In this 60-minute interactive virtual exchange on Amanda Jones, PhD, from the Division of Bioequivalence I (DBI) presents the Regulatory Background Aim and Scope of the ... Richard Novak, PhD Empower and Inspire: 3rd Annual Leigh Syndrome Symposium

Photo Gallery

CURE SYNGAP1 | CURE ID A Treatment Registry of Repurposed Drugs for SYNGAP1.mp4
2026 | SYNGAP1: Burden, Hope, and Progress
SYNGAP1 🧬 - Modulating Gene Regulation to Treat Gene Dosage-Associated Diseases - Dr Nadav Ahituv
What is the CURE Drug Repurposing Collaboratory and CURE ID?
CURE ID & CURE Drug Repurposing Collaboratory's (CDRC) Role in Drug Repurposing for NTDs & COVID-19
Funding Priorities.  Biorepository.  Genetic Testing. How to move for a clinical trial! #S10e197
Drug repurposing: Finding new uses for existing treatments
RASNet Introduces CURE ID RASopathies Survey
New Sanfilippo drug repurposing clinical trial; updates on other research + more
The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib
Injectable, Drug-Eluting Nanocrystals Prevent Fibrosis and Stricture Formation In Vivo
Role of additional (pharmaco)geneticsin treatment modifications and survival: Kjeld Schmiegelow
Sponsored
Sponsored
View Detailed Profile
CURE SYNGAP1 | CURE ID A Treatment Registry of Repurposed Drugs for SYNGAP1.mp4

CURE SYNGAP1 | CURE ID A Treatment Registry of Repurposed Drugs for SYNGAP1.mp4

CURE SYNGAP1

2026 | SYNGAP1: Burden, Hope, and Progress

2026 | SYNGAP1: Burden, Hope, and Progress

Learn more about

Sponsored
SYNGAP1 🧬 - Modulating Gene Regulation to Treat Gene Dosage-Associated Diseases - Dr Nadav Ahituv

SYNGAP1 🧬 - Modulating Gene Regulation to Treat Gene Dosage-Associated Diseases - Dr Nadav Ahituv

Learn more about SynGAP research at: https://www.syngapresearchfund.org In this video Dr Nadav Ahituv presents Modulating ...

What is the CURE Drug Repurposing Collaboratory and CURE ID?

What is the CURE Drug Repurposing Collaboratory and CURE ID?

Critical Path Institute's

CURE ID & CURE Drug Repurposing Collaboratory's (CDRC) Role in Drug Repurposing for NTDs & COVID-19

CURE ID & CURE Drug Repurposing Collaboratory's (CDRC) Role in Drug Repurposing for NTDs & COVID-19

Presentation by Heather Stone, Health Science Policy Analyst, US Food &

Sponsored
Funding Priorities.  Biorepository.  Genetic Testing. How to move for a clinical trial! #S10e197

Funding Priorities. Biorepository. Genetic Testing. How to move for a clinical trial! #S10e197

Funding Priorities. Biorepository. Genetic Testing. How to move for a clinical trial! #S10e197 Monday, February 2, 2026 - Week 6 ...

Drug repurposing: Finding new uses for existing treatments

Drug repurposing: Finding new uses for existing treatments

universityofnewcastle Professor Nikola Bowden, Co-director of HMRI's

RASNet Introduces CURE ID RASopathies Survey

RASNet Introduces CURE ID RASopathies Survey

CURE ID is

New Sanfilippo drug repurposing clinical trial; updates on other research + more

New Sanfilippo drug repurposing clinical trial; updates on other research + more

Episode 12: “A Close Look At Sanfilippo”

The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib

The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib

It

Injectable, Drug-Eluting Nanocrystals Prevent Fibrosis and Stricture Formation In Vivo

Injectable, Drug-Eluting Nanocrystals Prevent Fibrosis and Stricture Formation In Vivo

Johns Hopkins gastroenterologist Florin Selaru and nanomedicine researcher Laura Ensign discuss their work addressing one of ...

Role of additional (pharmaco)geneticsin treatment modifications and survival: Kjeld Schmiegelow

Role of additional (pharmaco)geneticsin treatment modifications and survival: Kjeld Schmiegelow

Childhood Cancer: Causes and Epidemiology The role of genetic predisposition and environment in development and

CareOregon My Easy Drug System (MEDS)

CareOregon My Easy Drug System (MEDS)

Learn about the CareOregon

Drug Repurposing — Perspective on an emerging pharmaceutical solution Promo

Drug Repurposing — Perspective on an emerging pharmaceutical solution Promo

In this 60-minute interactive virtual exchange on

Decoding the Guidance: Considerations for Waiver Requests for pH Adjusters in Generic Drug Products

Decoding the Guidance: Considerations for Waiver Requests for pH Adjusters in Generic Drug Products

Amanda Jones, PhD, from the Division of Bioequivalence I (DBI) presents the Regulatory Background Aim and Scope of the ...

Rapid prototyping with repurposed drugs to accelerate and clinically derisk therapeutics for LS

Rapid prototyping with repurposed drugs to accelerate and clinically derisk therapeutics for LS

Richard Novak, PhD Empower and Inspire: 3rd Annual Leigh Syndrome Symposium

Prof Ali Miserez on new method of delivering drugs into human cells via protein-based microdroplets

Prof Ali Miserez on new method of delivering drugs into human cells via protein-based microdroplets

Drugs used